NASA BioSentinel Probe Fails Yeast Growth Experiment

The deep-space mission successfully tracks radiation despite the unexpected expiration of its biological samples.

Updated on Oct. 29, 2026 in Life Sciences

Isometric editorial illustration of a cube-shaped satellite with solar arrays floating in space, representing a deep-space radiation research mission. — NASA scientists confirmed that yeast samples aboard the BioSentinel probe failed to grow, though the satellite continues providing vital radiation data. AI Illustration. Upload story photo >

Live Poll

Do you believe the scientific benefits of deep-space exploration justify the high costs and risks?

NASA determined that yeast samples aboard the 30-pound BioSentinel probe failed to grow during deep-space experiments initiated after its November 16, 2022, launch. Scientists concluded the biological material likely expired before the spacecraft even reached orbit.

Why it matters

This mission was designed to evaluate the impact of deep-space radiation on living cells to develop shielding solutions for future human spaceflight. While the primary biological experiment faced failure, the spacecraft continues to provide valuable radiation data.

The probe conducted four two-week tests using a mini laboratory known as the BioSensor. The satellite, a six-unit CubeSat weighing 30 pounds, was positioned over 48 million miles from Earth as of November 16, 2025.

The players

NASA

The United States government agency responsible for the nation's civilian space program and aeronautics research.

Ames Research Center

A major NASA research facility located in California that oversees mission management and science operations.

The details

Mission controllers at the Ames Research Center in California remotely triggered the experiments once the probe cleared Earth's protective magnetic field. Despite the loss of the yeast samples, the satellite's integrated radiation sensors remain operational and continue collecting data while the craft orbits the Sun.

November 16, 2022: The BioSentinel probe launched aboard Artemis I.
December 2022: The mission phase one experiment cycle began.
April 2023: The mission phase one experiment cycle concluded.
November 16, 2025: The probe marked three years of continuous deep-space observations.

The Big Picture

The BioSentinel mission serves as one of the 10 CubeSats launched during the Artemis I mission CubeSat deployment. This research effort marks a departure from standard success metrics for deep-space biological experiments.

Future human space exploration relies on the data collected by these sensors to design effective shielding against deep-space radiation. Successfully identifying these risks helps ensure the safety of astronauts traveling beyond the protection of Earth's magnetic field.

The takeaway

While the yeast experiments did not yield growth data, the continued operation of the probe's radiation sensors provides critical longitudinal information for long-term space flight. Scientists expect solar activity to remain high through 2026, offering more opportunities to study radiation environments.